Stock Events

Stock Events

Search...

Sangamo Therapeutics (SGMO) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.18

-0.11

-0.03

0.04

Details

Expected EPS

-0.117286

Actual EPS

-0.14

Surprise EPS

-0.02

Surprise Percent

+19.37%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.14 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.